Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Igor Golovniov/SOPA Images/LightRocket via Getty Images

In order to win Justice Department approval for their deal, Sprint and T-Mobile appear poised to sell spectrum and prepaid customers to Dish Network for a reported $5 billion.

Why it matters: Regulators in the past have blocked any deal that would have eliminated one of the current Big 4 mobile networks. An asset sale allows them to claim, at least on paper, that there will still be four players. But analysts have their doubts just how big a player Dish would be.

Dish has been a potential wireless entrant for some time, having scooped up a significant amount of spectrum in recent years — spectrum it is under pressure to use soon or risk losing. Back in 2013 Dish lost out in a bidding war with SoftBank for control of Sprint.

So it's not surprising that Sprint and T-Mobile are looking in Dish's direction, nor that regulators see it as a potential way to avoid admitting the deal will reduce competition.

Be smart: Even if the DoJ signs off on the deal, several states have already sued to block the merger, so they would have to be persuaded as well.

And many experts doubt that Dish alone will be a significant rival.

  • It's not so much a question of "Can Dish compete?" but rather whether it has the stomach to do so, New Street Research argued in a report Wednesday.
  • If they build a low-cost network, the firm argues, such a network can probably get customers. But whether Dish has the interest or skill to really build a network is far from certain.

Even if Dish does build a network, wireless consultant Chetan Sharma predicted that it won't want to be in the business for the long haul. Instead Dish would look to run it for a few years and ideally sell it back to one of the big three operators.

  • Even with the added spectrum, Sharma said Dish won't have much market share — around 2% of industry revenue vs. Sprint's current 12%. Also, he said Dish lacks the capital to invest long term.

Go deeper

Ina Fried, author of Login
8 mins ago - Technology

Apple sets September quarter sales record despite later iPhone launch

Apple CEO Tim Cook, speaking at the Apple 12 launch event in October. Photo: Apple

Apple on Thursday reported quarterly sales and earnings that narrowly exceeded analysts estimates as the iPhone maker continued to see strong demand amid the COVID-19 pandemic.

What they's saying: The company said response to new products, including the iPhone 12 has been "tremendously positive" but did not give a specific forecast for the current quarter.

Supreme Court rejects second GOP effort to cut absentee ballot deadline in N.C.

Photo: Robert Alexander/Getty Images

The Supreme Court, for the second time in two days, rejected a GOP request to shorten the deadline mail-in ballots must be received by North Carolina officials to be counted.

The state of play: The state's deadline had been extended from 3 days to 9 days post-Election Day.

2 hours ago - Podcasts

The vaccine race turns toward nationalism

The coronavirus pandemic is worsening, both in the U.S. and abroad, with cases, hospitalizations and deaths all rising.

Axios Re:Cap digs into the state of global vaccine development — including why the U.S. and China seem to going at it alone — with medicinal chemist and biotech blogger Derek Lowe.